Zscaler to Deliver Generative AI-powered Zero Trust Security Innovations in Collaboration with NVIDIA
June 11, 2024 08:05 ET
|
Zscaler, Inc.
LAS VEGAS, June 11, 2024 (GLOBE NEWSWIRE) -- Zscaler Zenith Live -- Zscaler, Inc. (NASDAQ: ZS), a leader in cloud security, today announced a collaboration with NVIDIA to accelerate AI-powered...
Shoals Technologies Group, Inc. Announces $150 Million Share Repurchase Program and Entry Into $25 Million Accelerated Share Repurchase Agreement
June 11, 2024 08:00 ET
|
Shoals Technologies Group
PORTLAND, Tenn., June 11, 2024 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (“Shoals” or the “Company”) (Nasdaq: SHLS), a leading provider of electrical balance of system solutions for the...
ARKO Corp. Named to Fortune 500 List for Third Consecutive Year
June 11, 2024 08:00 ET
|
ARKO CORP.
ARKO announced to 2024 Fortune 500 list
NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office
June 11, 2024 08:00 ET
|
NewAmsterdam Pharma N.V.
-- New patent extends patent term for obicetrapib until July 2043 -- NAARDEN, the Netherlands and MIAMI, June 11, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or...
Concentrix Schedules Release of Second Quarter 2024 Financial Results and Webcast of Investor Conference Call
June 11, 2024 08:00 ET
|
Concentrix Corporation
NEWARK, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, plans to announce its fiscal second quarter 2024 financial results...
Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries
June 11, 2024 08:00 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, June 11, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced a collaboration with GSK aimed at...
Envoy Medical Announces Addition of Medical Device Manufacturing Experience to its Board of Directors to Prepare for Scaling
June 11, 2024 08:00 ET
|
Envoy Medical, Inc
WHITE BEAR LAKE, Minn., June 11, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH) today announced the appointment of Michael Crowe to the Envoy Medical Board of...
Oxbridge Re’s RWA Subsidiary SurancePlus reports 49% Realized return on its 2023/24 DeltaCat Re Tokenized Reinsurance Securities
June 11, 2024 08:00 ET
|
Oxbridge Re Holdings Limited
GRAND CAYMAN, Cayman Islands, June 11, 2024 (GLOBE NEWSWIRE) -- Oxbridge Re Holdings Limited (Nasdaq: OXBR) (“The Company”), together with its subsidiaries is engaged in the business of tokenized...
Predictive Oncology Develops Novel Stem Cell Expression System for the Production of Functional and Stable G-Protein Coupled Receptors (GPCRs)
June 11, 2024 08:00 ET
|
Predictive Oncology Inc.
Company files expansive intellectual property protection for “Membrane Protein Factory” to produce purified and biologically active membrane proteins for drug development External sources value...
CervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodies
June 11, 2024 08:00 ET
|
CervoMed Inc.
- Topline data expected in December 2024 - - Phase 2b design optimized for success; clear path to market in this high value indication expected with positive result - BOSTON, June 11, 2024 (GLOBE...